Catalyst Wire Dossier Catalyst Wire Dossier

VedAryo

Vedolizumab · AryoGen Pharmed Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VedAryo, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation

See pricing